Opzelura^® (ruxolitinib) cream

This page is intended as reference information for the general public in The United Kingdom & Ireland.

For more information on this product, please visit the electronic Medicines Compendium (eMC).

If you get any side effects when taking this or any other medicine, talk to your doctor or other relevant health professional, e.g. pharmacist, nurse. This includes any possible side effects not listed in the packaging leaflet. In the United Kingdom you can also resport side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search the Google Play or Apple App Store for MHRA Yellow Card. In Ireland adverse events can be reported via HPRA Pharmacovigilance at www.hpra.ie. By reporting side effects, you can help provide more information on the safety of this medicine.

Incyte is unable to provide advice on personal medical matters. Please consult your doctor or other relevant health professional for specific, health-related advice and support.